Conformal radiotherapy in combination with cetuximab for stage Т1–2 tongue cancer with N1–2b regional metastases detected after preventive lymphadenectomy

Conformal radiotherapy in combination with cetuximab for stage Т1–2 tongue cancer with N1–2b regional metastases detected after preventive lymphadenectomy

The study objective is to analyze the experience of conformal radiotherapy in combination with cetuximab for cervical lymph node (LN) metastasis in patients with early-stage tongue cancer who had undergone multicomponent surgeries.Materials and methods. This retrospective study included 48 patients...

Full description

Bibliographic Details
Main Authors:	D. V. Sikorsky, N. V. Kanishcheva, S. O. Podvyaznikov, D. V. Skamnitsky, S. V. Smetanina, A. M. Ermolaeva, K. V. Bazanov, S. R. Pakhomov
Format:	Article
Language:	Russian
Published:	ABV-press 2020-02-01
Series:	Opuholi Golovy i Šei
Subjects:	tongue cancer surgical treatment metastasis conformal radiotherapy cetuximab mucositis trichomonas tenax
Online Access:	https://ogsh.abvpress.ru/jour/article/view/449

Similar Items

Clinical and epidemiological characteristics and morphological peculiarities of urogenital trichomoniasis nowadays
by: H. I. Mavrov, et al.
Published: (2020-06-01)

Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue
by: Yasuyuki Asada, et al.
Published: (2021-07-01)

ІНДИВІДУАЛЬНА ПРОФІЛАКТИКА ПРОТОЗОЙНИХ РЕІНВАЗІЙ СЕЧОСТАТЕВОЇ СИСТЕМИ, ВИКЛИКАНИХ НЕ TRICHOMONAS VAGINALIS
by: P.V. Fedorych
Published: (2019-07-01)

Observational cross-sectional study of Trichomonas tenax in patients with periodontal disease attending a Chilean university dental clinic
by: Casandra Bracamonte-Wolf, et al.
Published: (2019-09-01)

Prevalence and Risk Factors of Oral Cavity Protozoa (Entamoeba gingivalis and Trichomonas tenax) among Patients with Dental Cavity Caries
by: Hossein Mahmoudvand, et al.
Published: (2018-10-01)

A Brief Overview of the Results of the Studies on the Prevalence of Trichomonas Tenax in Iran
by: Reza Hajihossein, et al.
Published: (2020-04-01)

STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
by: O. I. Kit, et al.
Published: (2019-09-01)

Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy
by: A. A. Lyanova, et al.
Published: (2020-07-01)

Prevalence of oral <i>Entamoeba gingivalis</i> and <i>Trichomonas tenax </i>in patients with periodontal disease and healthy population in Shiraz, southern Iran
by: Ghabanchi J, et al.
Published: (2010-01-01)

Molecular identification of Trichomonas tenax in the oral environment of domesticated animals in Poland – potential effects of host diversity for human health
by: Monika Dybicz, et al.
Published: (2018-09-01)

DETAILIZATION OF MIDLINE MANDIBULOTOMY AS A SURGICAL ACCESS FOR THE TREATMENT OF THE POSTERIOR THIRD OF THE TONGUE
by: D. V. Sikorsky, et al.
Published: (2015-04-01)

Protozoans in subgingival biofilm: clinical and bacterial associated factors and impact of scaling and root planing treatment
by: Marie Dubar, et al.
Published: (2020-01-01)

Interleukin-1 signaling contributes to the anti-tumor efficacy of Cetuximab in head and neck squamous cell carcinoma
by: Espinosa-Cotton, Madelyn
Published: (2018)

Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
by: A. M. Mudunov, et al.
Published: (2020-11-01)

A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer
by: Markus Hecht, et al.
Published: (2021-07-01)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
by: Julie E. Bauman, et al.
Published: (2020-06-01)

Effects of Cetuximab Combined with Celecoxib on Apoptosis and KDR and AQP1  Expression in Lung Cancer
by: Honggang XIA, et al.
Published: (2013-12-01)

Organizing pneumonia secondary to cetuximab in a patient with colorectal cancer
by: Abdulaziz AlGhulayqah, et al.
Published: (2019-09-01)

Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
by: Seber S, et al.
Published: (2016-02-01)

Human pseudomyiasis caused by Eristalis tenax (Linnaeus) (Diptera: Syrphidae) in Goiás Pseudomiíase humana causada por Eristalis tenax (Linnaeus) (Diptera: Syrphidae) em Goiás
by: Marco Tulio A. Garcia-Zapata, et al.
Published: (2005-04-01)

Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
by: Ying-nan Yang, et al.
Published: (2018-10-01)

Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
by: Cui J, et al.
Published: (2019-11-01)

PUM1 Is Overexpressed in Colon Cancer Cells With Acquired Resistance to Cetuximab
by: Qizhi Liu, et al.
Published: (2021-08-01)

Transgenic goats producing an improved version of cetuximab in milk
by: Götz Laible, et al.
Published: (2020-11-01)

Lutetium 177-Labeled Cetuximab Evaluation for Radioimmunotherapeutic Applications
by: Kamal Yavari, et al.
Published: (2012-06-01)

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
by: Madelyn Espinosa-Cotton, et al.
Published: (2019-03-01)

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab
by: Joan Manel Gasent Blesa, et al.
Published: (2012-12-01)

Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01)

Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?
by: Giuliani Jacopo, et al.
Published: (2014-04-01)

Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
by: Alessandra Chen, et al.
Published: (2018-01-01)

Influence of HER2 Overexpression on Response to Cetuximab in Patients with Metastatic Colorectal Cancer, Tehran, Iran
by: Rambod MOZAFARI, et al.
Published: (2018-06-01)

TENAX AS A MEASURE OF BIOAVAILABILITY AND REMEDIATION SUCCESS ON THE OTTAWA RIVER.
by: Mackenbach, Elizabeth M.
Published: (2013)

Surgical resection for a huge recurrent right colon carcinoma after cetuximab plus FOLFIRI
by: Chou-Chen Chen, et al.
Published: (2021-10-01)

Cetuximab-related Hypersensitivity Reactions in Northeast Tennessee
by: Angles, M., et al.
Published: (2012)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
by: Donata Galbiati, et al.
Published: (2019-12-01)

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Sheng YANG, et al.
Published: (2016-05-01)

Myiasis gastrointestinal humana por Eristalis tenax Gastrointestinal human myiasis for Eristalis tenax
by: Marcelo Kun, et al.
Published: (1998-08-01)

Postoperative conformal radiotherapy of locally advanced squamous-cell oropharyngeal cancer
by: N. V. Kanishcheva, et al.
Published: (2019-04-01)

Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells
by: S. Zhang, et al.
Published: (2017-11-01)

Dermopathy associated with cetuximab and panitumumab: investigation of the usefulness of moisturizers in its management
by: Watanabe S, et al.
Published: (2017-09-01)

Cannot write session to /tmp/vufind_sessions/sess_a6go7iv126rj56dmho9efuegp6